Veit Scheble

2.4k total citations
23 papers, 1.1k citations indexed

About

Veit Scheble is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Veit Scheble has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Veit Scheble's work include Prostate Cancer Treatment and Research (10 papers), Molecular Biology Techniques and Applications (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Veit Scheble is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Molecular Biology Techniques and Applications (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Veit Scheble collaborates with scholars based in Germany, United States and Switzerland. Veit Scheble's co-authors include Sven Perner, Falko Fend, Karen Petersen, Glen Kristiansen, Mark A. Rubin, Annette Staebler, Theresia Wilbertz, Markus Reischl, Claudia Lengerke and Martin Braun and has published in prestigious journals such as CHEST Journal, European Journal of Cancer and The Journal of Pathology.

In The Last Decade

Veit Scheble

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veit Scheble Germany 16 660 488 333 306 96 23 1.1k
Carlynn Willmore‐Payne United States 15 360 0.5× 328 0.7× 414 1.2× 196 0.6× 146 1.5× 30 832
Joana Vieira Portugal 14 344 0.5× 293 0.6× 220 0.7× 134 0.4× 85 0.9× 39 701
Mitsuyo Yoshihara Japan 18 341 0.5× 271 0.6× 295 0.9× 159 0.5× 130 1.4× 37 868
Olaf Neumann Germany 15 492 0.7× 355 0.7× 493 1.5× 483 1.6× 122 1.3× 38 1.1k
Kerry D. Lynch United States 6 352 0.5× 319 0.7× 285 0.9× 233 0.8× 137 1.4× 7 887
Alice M. Walsh United States 13 301 0.5× 260 0.5× 344 1.0× 180 0.6× 51 0.5× 24 878
Naoki Kitabayashi United States 17 844 1.3× 525 1.1× 207 0.6× 472 1.5× 64 0.7× 19 1.5k
Wesley O. Greaves United States 13 352 0.5× 217 0.4× 376 1.1× 249 0.8× 114 1.2× 24 857
David Pook Australia 14 309 0.5× 631 1.3× 454 1.4× 217 0.7× 88 0.9× 60 976
Anna Dowe United Kingdom 13 537 0.8× 335 0.7× 245 0.7× 264 0.9× 56 0.6× 15 951

Countries citing papers authored by Veit Scheble

Since Specialization
Citations

This map shows the geographic impact of Veit Scheble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veit Scheble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veit Scheble more than expected).

Fields of papers citing papers by Veit Scheble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veit Scheble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veit Scheble. The network helps show where Veit Scheble may publish in the future.

Co-authorship network of co-authors of Veit Scheble

This figure shows the co-authorship network connecting the top 25 collaborators of Veit Scheble. A scholar is included among the top collaborators of Veit Scheble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veit Scheble. Veit Scheble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scheble, Veit, et al.. (2023). Implementing Remote Patient Monitoring for Patients During Systemic Cancer Therapy. Studies in health technology and informatics. 302. 1019–1020.
2.
Scheble, Veit, et al.. (2021). Role of Rendezvous-Procedure in the Treatment of Complications after Laparoscopic Sleeve Gastrectomy. Journal of Clinical Medicine. 10(23). 5670–5670. 5 indexed citations
3.
4.
Gsponer, Joël, Martin Braun, Veit Scheble, et al.. (2014). ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 17(2). 126–131. 17 indexed citations
5.
Scheble, Veit, Petra M. Bareiss, Anna Fischer, et al.. (2013). SOX2 Expression and Prognostic Significance in Ovarian Carcinoma. International Journal of Gynecological Pathology. 32(4). 358–367. 32 indexed citations
6.
Menon, Roopika, Mario C. Deng, Angela Queisser, et al.. (2013). Somatic copy number alterations by whole‐exome sequencing implicates YWHAZ and PTK2 in castration‐resistant prostate cancer. The Journal of Pathology. 231(4). 505–516. 26 indexed citations
7.
Braun, Martin, Diane Goltz, David Adler, et al.. (2012). ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodies. Prostate Cancer and Prostatic Diseases. 15(2). 165–169. 63 indexed citations
8.
Göke, Friederike, Alina Franzen, Roopika Menon, et al.. (2012). Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using Fibroblast Growth Factor Receptor Inhibitors. CHEST Journal. 142(4). 1020–1026. 45 indexed citations
9.
Scheble, Veit, Martin Braun, Christian Ruiz, et al.. (2012). ERG rearrangement in local recurrences compared to distant metastases of castration-resistant prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 461(2). 157–162. 10 indexed citations
10.
Braun, Martin, Diana Boehm, Wenzel Vogel, et al.. (2012). Improved Method of Detecting the ERG Gene Rearrangement in Prostate Cancer Using Combined Dual-Color Chromogenic and Silver In Situ Hybridization. Journal of Molecular Diagnostics. 14(4). 322–327. 6 indexed citations
11.
Wagner, Patrick, Theresia Wilbertz, Karen Petersen, et al.. (2011). Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer. 74(1). 118–123. 33 indexed citations
12.
Braun, Martin, Veit Scheble, Roopika Menon, et al.. (2011). Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer. Histopathology. 58(7). 1028–1036. 31 indexed citations
13.
Maier, Sebastian H., Theresia Wilbertz, Martin Braun, et al.. (2011). SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Human Pathology. 42(8). 1078–1088. 95 indexed citations
14.
Lengerke, Claudia, Tanja Fehm, Ralf Kurth, et al.. (2011). Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer. 11(1). 42–42. 161 indexed citations
15.
Wilbertz, Theresia, Patrick Wagner, Karen Petersen, et al.. (2011). SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Modern Pathology. 24(7). 944–953. 165 indexed citations
16.
Esgueva, Raquel, Sven Perner, Christopher J. Lafargue, et al.. (2010). Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort. Modern Pathology. 23(4). 539–546. 121 indexed citations
17.
Scheble, Veit, Martin Braun, Theresia Wilbertz, et al.. (2010). ERG rearrangement in small cell prostatic and lung cancer. Histopathology. 56(7). 937–943. 49 indexed citations
18.
Scheble, Veit, Martin Braun, Rameen Beroukhim, et al.. (2010). ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor. Modern Pathology. 23(8). 1061–1067. 90 indexed citations
19.
Schmidt, Frank P., Veit Scheble, Kirsten D. Mertz, Sven Perner, & Mark A. Rubin. (2009). Eine häufige Genfusion im Prostatakarzinom. DMW - Deutsche Medizinische Wochenschrift. 134(28/29). 1483–1486. 1 indexed citations
20.
Scholl, Sebastian, Veit Scheble, Anita Heller, et al.. (2007). Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia. European Journal Of Haematology. 80(3). 208–215. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlynn Willmore‐Payne Breakdown of academic impact, for papers by Joana Vieira Breakdown of academic impact, for papers by Mitsuyo Yoshihara Breakdown of academic impact, for papers by Olaf Neumann Breakdown of academic impact, for papers by Kerry D. Lynch Breakdown of academic impact, for papers by Alice M. Walsh Breakdown of academic impact, for papers by Naoki Kitabayashi Breakdown of academic impact, for papers by Wesley O. Greaves Breakdown of academic impact, for papers by David Pook Breakdown of academic impact, for papers by Anna Dowe
Rankless by CCL
2026